<DOC>
	<DOCNO>NCT03008096</DOCNO>
	<brief_summary>In LVAD ( Left-Ventricular Assist Device ) patient , evidence lack regard safety efficacy Laparoscopic Sleeve Gastrectomy ( LSG ) mean reach Body Mass Index ( BMI ) within list criterion heart transplantation . To knowledge , first prospective study evaluate laparoscopic sleeve gastrectomy LVAD patient bridge-to-candidacy heart transplantation .</brief_summary>
	<brief_title>Laparoscopic Sleeve Gastrectomy Bridge-to-Candidacy Obese Left-Ventricular Assist Device Patients</brief_title>
	<detailed_description>Continuous-flow left-ventricular assist device increasingly use treatment acute chronic end-stage heart failure ( Mancini 2015 ) . Three main implantation strategy exist : destination therapy ( support end life ) , bridge transplantation ( support transplantation ) , bridge candidacy ( support transplantation criterion meet ) . Although LVAD support delivers excellent short-term long-term result , current gold standard last resort treatment end-stage heart failure remain orthotopic heart transplantation ( Lund 2015 ) . Obesity increase mortality heart transplantat recipient therefore include 2006 transplantation criterion . The heart transplant program Medical University Vienna use BMI 30 kg/m2 upper limit list heart transplantation ( Mehra 2016 ) . Ambulatory patient CF-LVAD support tendency gain weight reduce physical fitness , inability work , genetic predisposition . In many case , binge eating use cop mechanism alleviate depression anxiety associate heart failure LVAD therapy . Conservative measure reduce weight increase physical fitness fail many patient . As result , many case patient remain ineligible heart transplantation month year . For entire period ineligibility , subject constant life-threatening risk LVAD treatment , importantly ischemic hemorrhagic stroke , pump thrombosis , infection , right heart failure , bleed episode gastrointestinal tract organ system ( Kirklin 2015 ) . Bariatric surgery show superior conservative measure weight reduction morbidly obese patient . Laparoscopic sleeve gastrectomy , one commonly employ bariatric procedure , reduces body weight non-malabsorptive mechanism ( Colquitt 2014 ) . Gastric volume reduction achieve resection along stomach 's great curvature creation gastric tube , lead reduce capacity ingest food , decrease appetite early satiety . In contrast malabsorptive bariatric procedure , resorption efficacy immunosuppressive drug , inevitable feature post-transplant therapy , minimally influence follow sleeve gastrectomy . Furthermore , less requirement substitution trace element vitamin , example Vitamin B12 . Due fact majority obese LVAD patient within BMI range 30 40 kg/m2 , moderate weight loss achieve sleeve gastrectomy expect sufficient reach eligibility criterion heart transplantation . It unclear , whether laparoscopic sleeve gastrectomy effective safe patient CF-LVAD . The literature limit case report retrospective series 4 patient . This first prospective series include 4 patient specific aim enable obese LVAD support patient reach BMI within list criterion heart transplantation mean laparoscopic sleeve gastrectomy .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Ambulatory patient LVADsupport endstage heart failure BridgetoCandidacy strategy BMI &gt; 35kg/m2 Failure reach BMI &lt; 30kg/m2 conservative measure Age &gt; 18 year Ability give inform consent Absolute contraindication subsequent heart transplantation obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>